Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome

被引：0
|
作者：
Vettore, Elia [1 ]
Piano, Salvatore [1 ]
Tonon, Marta [1 ]
Romano, Antonietta [1 ]
Gambino, Carmine [1 ]
Bertoli, Eleonora [1 ]
Fasolato, Silvano [1 ]
Zanus, Giacomo [2 ]
Boccagni, Patrizia [2 ]
Burra, Patrizia [3 ]
Cillo, Umberto [2 ]
Angeli, Paolo [1 ]
机构：
[1] Univ Padua, Dept Med DIMED, UIMH, Padua, Italy
[2] Dept Surg Oncol & Gastroenterol, Hepatobiliary Surg & Liver Transplantat Unit, Padua, Italy
[3] Gastroenterol Multivisceral Transplant Unit, Padua, Italy
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)31142-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
FRI-403
引用
收藏
页码：E572 / E572
页数：1
相关论文
共 50 条
  • [21] Treatment Response to Terlipressin Plus Albumin Varies by Precipitating Factor in Patients With Hepatorenal Syndrome Type 1
    Frederick, Richard T.
    Lim, Nicholas
    Khan, Mohammad
    Zafar, Zunaira
    Jamil, Khurram
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S865 - S866
  • [22] The Survival-Prognosis of Patients with Liver Cirrhosis and Hepatorenal Syndrome (HRS) is associated with the response to Terlipressin and Human Albumin
    Nguyen-Tat, M.
    Goetz, E.
    Ahrens, J.
    Rey, J.
    Sivanathan, V.
    Woerns, M.
    Galle, P.
    Marquardt, J.
    INTERNIST, 2015, 56 : 29 - 29
  • [23] Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome
    Wong, F.
    Pappas, S. C.
    Curry, M. P.
    Reddy, K. R.
    Rubin, R. A.
    Porayko, M. K.
    Gonzalez, S. A.
    Mumtaz, K.
    Lim, N.
    Simonetto, D. A.
    Sharma, P.
    Sanyal, A. J.
    Mayo, M. J.
    Frederick, R. T.
    Escalante, S.
    Jamil, K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09): : 818 - 828
  • [24] RESPONSE AND PREDICTORS OF RESPONSE TO TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME
    Owen, Emily
    Yeary, Julianne
    Juang, Paul
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [25] Terlipressin and Albumin in Patients with Cirrhosis and Type I Hepatorenal Syndrome
    Sergio Neri
    Davide Pulvirenti
    Mariano Malaguarnera
    Bruno M. Cosimo
    Gaetano Bertino
    Luca Ignaccolo
    Sebasiano Siringo
    Pietro Castellino
    Digestive Diseases and Sciences, 2008, 53 : 830 - 835
  • [26] Terlipressin for the treatment of hepatorenal syndrome in patients with cirrhosis
    Angeli, Paolo
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (03): : 241 - 248
  • [27] PREDICTIVE FACTORS OF RESPONSE TO THERAPY IN PATIENTS WITH CIRRHOSIS AND HEPATORENAL SYNDROME TREATED WITH TERLIPRESSIN AND ALBUMIN
    Nazar, Andre
    Guevara, Monico
    Marinelli, Marcella
    Martin-llahi, Marta
    Pepin, Marie-Noeele
    Baccaro, Maria Eugenia
    Arroyo, Vicente
    Gines, Pere
    HEPATOLOGY, 2008, 48 (04) : 1058A - 1058A
  • [28] THE IMPACT OF MELD SCORE AND ACLF GRADE ON OUTCOMES OF HEPATORENAL SYNDROME FOLLOWING TREATMENT WITH TERLIPRESSIN AND ALBUMIN IN PATIENTS WITH ALCOHOL-ASSOCIATED HEPATITIS
    Weinberg, Ethan M.
    Jamil, Khurram
    Deng, Richard
    Reddy, K. Rajender Rajender
    HEPATOLOGY, 2023, 78 : S1365 - S1366
  • [29] Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome
    Neri, Sergio
    Pulvirenti, Davide
    Malaguarnera, Mariano
    Cosimo, Bruno M.
    Bertino, Gaetano
    Ignaccolo, Luca
    Siringo, Sebasiano
    Castellino, Pietro
    DIGESTIVE DISEASES AND SCIENCES, 2008, 53 (03) : 830 - 835
  • [30] Predictors of Response to Therapy with Terlipressin and Albumin in Patients with Cirrhosis and Type 1 Hepatorenal Syndrome
    Nazar, Andre
    Henrique Pereira, Gustavo
    Guevara, Monica
    Martin-Llahi, Marta
    Pepin, Marie-Noelle
    Marinelli, Marcella
    Sola, Elsa
    Eugenia Baccaro, Maria
    Terra, Carlos
    Arroyo, Vicente
    Gines, Pere
    HEPATOLOGY, 2010, 51 (01) : 219 - 226
12345